Previously, a somatic mutation in ARID1A has been found in 46–57% of ovarian clear cell carcinomas [35,36], 30% of ovarian endometrioid carcinomas [34], and 40% of uterine endometrioid carcinomas [37]. This evidence concerns the gene ARID1A and ovarian clear cell cancer.